Prospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Endosc. May 16, 2024; 16(5): 259-272
Published online May 16, 2024. doi: 10.4253/wjge.v16.i5.259
Table 1 Characteristics of patients and lesions (intention-to-treat population), n (%)
Characteristics
Experimental group
Conventional group
P value
No. of participants8680
Age, mean ± SD, yr59.84 ± 8.4059.75 ± 9.210.9491
BMI, mean ± SD, kg/m223.89 ± 3.3523.49 ± 2.290.3721
Sex0.7982
        Male51 (59.30)49 (61.25)
        Female35 (40.70)31 (38.75)
Basic diseases
        Diabetes9 (10.47)8 (10.00)0.9212
        Hypertension14 (16.28)6 (7.50)0.0832
        Coronary heart disease4 (4.65)4 (5.00)0.9162
Family history of esophageal cancer or stomach cancer0.8002
        No67 (77.91)61 (76.25)
        Yes19 (22.09)19 (23.75)
Smoking0.8992
        No-smoker46 (53.49)42 (52.50)
        Smoker40 (46.51)38 (47.50)
Smoking index0.6182
        ≤ 20015 (17.44)11 (13.75)
        200-40014 (16.28)13 (16.25)
        ≥ 40011 (12.79)14 (17.50)
Alcohol drinking0.7122
        No-drinker39 (45.35)34 (42.50)
        Drinker47 (54.65)46 (57.50)
Alcohol ingestion, g/d0.8332
        ≤ 2023 (26.74)20 (25.00)
        20-6013 (15.12)13 (16.25)
        ≥ 6011 (12.79)13 (16.25)
Prefer hot dishes/hot tea0.4592
        No50 (59.14)51 (63.75)
        Yes36 (41.86)29 (36.25)
Prefer spicy food0.2272
        No76 (88.37)75 (93.75)
        Yes10 (11.63)5 (6.25)
Prefer pickled dishes0.0952
        No77 (89.53)77 (96.25)
        Yes9 (10.47)3 (3.75)
Multiple Lugol’s voiding lesions0.2082
        No52 (65.00)57 (75.00)
        Yes28 (35.00)19 (25.00)
Lesion location0.1972
        Upper thoracic esophagus12 (13.95)8 (10.00)
        Middle thoracic esophagus44 (51.16)52 (65.00)
        Lower thoracic esophagus30 (34.88)20 (25.00)
Maximum diameter0.1342
        Lesion size ≤ 0.5 cm65 (75.58)54 (67.50)
        Lesion size > 0.5 cm21 (24.42)26 (32.50)
Morphology0.3242
        Quasi circular31 (36.05)30 (37.50)
        Bar-type3 (3.49)7 (8.75)
        Irregular shape52 (60.47)43 (53.75)
Biopsy pathology0.5062
        Squamous epithelial hyperplasia77 (89.53)74 (92.50)
        Low grade intraepithelial neoplasia9 (10.47)6 (7.50)
Follow-up time28.92 ± 6.0430.48 ± 5.880.09581